Categories Earnings, Retail

Monster Beverage posts downbeat earnings and revenue in first quarter

Monster Beverage Corporation (MNST) reported a 14.7% increase in net sales to $850.9 million for the first quarter of 2018 compared to the prior-year period. Net changes in foreign currency exchange rates had a favorable impact on net sales of $17.7 million. Shares of Monster Beverage fell about 5% in the after-market session owing to the results that missed Street’s expectations.

Net income increased 21.4% to $216.1 million and EPS improved 23.1% to $0.38 from the first quarter of 2017.

Net sales for the Monster Energy Drinks segment grew 16.7% to $780.5 million. Net sales in the Strategic Brands segment dropped 3.3% to $65.8 million. In the Other segment, net sales slipped to $4.7 million from $5.5 million in the prior-year period.

Net sales to customers outside the United States surged 26.8% to $242.1 million in the recently ended quarter.

Monster is progressing in its strategic alignment with the Coca-Cola system bottlers. During the first quarter, the company completed its transition to the Coca-Cola bottlers in Minnesota. Monster also launched the Monster Energy brand with the Coca-Cola bottlers in Argentina.

Subsequent to Q1 2018, the Corona, California-based company relaunched Monster Energy with a Coca-Cola bottler in a lead market in India. Monster is planning a transition in Ecuador, as well as launches of Monster Energy in Uruguay and in a number of other countries in the Middle East and Africa with Coca-Cola bottlers over the coming quarters.

In the U.S., the company rebranded its Monster Extra Strength Nitrous Technology line to the Monster MAXX line and launched Monster Rehab White Dragon Tea.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top